ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 81 filers reported holding ADURO BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $83,000 | +13.7% | 34,241 | +7.9% | 0.01% | -65.9% |
| Q2 2020 | $73,000 | +5.8% | 31,734 | -46.1% | 0.04% | +412.5% |
| Q4 2019 | $69,000 | -70.8% | 58,845 | +209.7% | 0.01% | -38.5% |
| Q3 2016 | $236,000 | -7.1% | 19,000 | -4.0% | 0.01% | -18.8% |
| Q1 2016 | $254,000 | -43.6% | 19,800 | +23.8% | 0.02% | -27.3% |
| Q4 2015 | $450,000 | +89.1% | 16,000 | +30.1% | 0.02% | +83.3% |
| Q3 2015 | $238,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |